PLACES ARE LIMITED TO 30 PARTICIPANTS.
At the end of these conferences, participant will be able to:
Act now in people living with Type 2 Diabetes (CEM-278)
1. Apply the recently published Diabetes Canada Blood Glucose Monitoring in Adults and Children Update 2021 Recommendations;
2. Describe the differences between intermittently scanned (isCGM) and real-time Continuous Glucose Monitoring (rtCGM);
3. Integrate time-in-range (TIR), glycemic variability (GV) and ambulatory glucose profile (AGP) to facilitate individualized management of diabetic patients.
Insulin therapy in the primary care practice
1. Learn how to use the Ambulatory Glucose Profile and other key reports in order to identify patients who are not controlled based on Time-In-Range criteria;
2. Learn how to identify patients that will benefit from prandial insulin and describe how to initiate and safely titrate therapy;
3. Identify patients who are at higher risk for hypoglycemia and describe strategies for preventing hypoglycemia;
Recent guideline changes in vaccine recommendations
1. Describe the changing landscape in pneumococcal vaccination and the role of Prevnar 15, Prevnar 20 and Pneumovax 23 in adults;
2. Cite vaccination recommendations for high risk clinical conditions including immunocompromised individuals. Identify which biologics influence vaccination recommendations;
3. Cite guideline based immunisation recommendations including meningococcal vaccination;
4. Optimize the conversation about vaccine preventable diseases in a post-pandemic environment.
Moderator : Dr. Jonathan Singerman. Conferences given by Dr. Peter Assimakopoulos and Dr. Dominique Tessier.
From 17 h 30 to 17 h 45, Welcome
From 17 h 45 to 18 h 15, Meal
From 18 h 15 to 19 h 15, Conference
From 19 h 15 to 20 h 15, Conference
From 20 h 15 to 20 h 25, Break
From 20 h 25 to 21 h 25, Conference
This conference will be held at La Sirène de la Mer Restaurant, located at 114 Av. Dresden, Mont-Royal, QC, H3P 2B6.
The AMOM recommends that all participants follow the provincial health guidelines related to the COVID-19 pandemic.
Participants acknowledge and accept the health risks that may be associated with in-person participation and understand that they are solely responsible for assessing their own health and taking appropriate safety measures for their situation.
An attendance list can be sent to the pharmaceutical company after the activity, if requested. By this registration, the general practitioner and/or any other healthcare professional consents to the disclosure of his first and last name to the pharmaceutical company.
The pharmaceutical company agrees not to communicate this information without the consent of the participant.
If you do not want your first and last name disclosed, please contact Ms. Aline Sabbagh at email@example.com indicating the activity number.
Recognition of Educational Activities
L’Association des médecins omnipraticiens de Montréal, under the aegis of the FMOQ, recognizes 3.00 hours of professional development activity, of category 1, as required by the professional development regulations of the CMQ. The FMOQ number to retrieve your certificate is 84873.
This activity has received an educational subsidy from Laboratoire Abbott Cie.